ECDEYO

Amgen Inc.

Application Filed: 2022-03-02

Trademark Application Details

Mark For: ECDEYO™ trademark registration is intended to cover the categories of pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure. [all]

Status

2022-03-09 UTC

LIVE APPLICATION Awaiting Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Website	www.amgen.com
Research	OneLook Acronym Finder
Serial Number	97291156
Mark Literal Elements	ECDEYO
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	NEW APPLICATION PROCESSING 2022-03-07
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	005: Adhesives 006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Elsa D. Lemoine
Attorney Docket Number	TM-2171-US-1

Timeline

2022-03-02	Application Filed
2022-03-05	Location: NEW APPLICATION PROCESSING
2022-03-05	Status: Live/Pending
2022-03-05	Transaction Date
2022-03-07	Location: NEW APPLICATION PROCESSING
2022-03-07	Status: New application will be assigned to an examining attorney approximately 6 months after filing date.

Trademark Parties (Applicants & Owners)

Party:	Amgen Inc.
Address	One Amgen Center Drive Trademark Operations-MS-28-5A Thousand Oaks, CALIFORNIA UNITED STATES 913201799
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Application		2022-03-02
Drawing		2022-03-02

Attorney of Record

ELSA D. LEMOINE
AMGEN INC.
TRADEMARK OPERATIONS-MS-28-5A
ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA 91320-1799

Good, Services, and Codes

IC 005. US 005 006 018 044 046 051 052. G & S: pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

International Codes:	5
U.S. Codes:	005,006,018,044,046,051,052

Type Code	Type
GS0051	pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Type Code

Type

GS0051

pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Trademark Filing History

Description	Date	Proceeding Number
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2022-03-07
NEW APPLICATION ENTERED IN TRAM	2022-03-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.